Phio Pharmaceuticals Corp (PHIO)

Stock price, financials, and technical signals for Phio Pharmaceuticals Corp (PHIO).

$2.06

-0.16

(-7.21%)

As of 01/31/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

PHIO Performance Snapshot


1-Week Chg

-6.79%

1-Month Chg

14.44%

3-Month Chg

-30.87%

6-Month Chg

-35.63%

1-Year Chg

-61.47%

Year-To-Date Chg

8.42%

Beta 1-Year

4.05

Beta 5-Year

1.24

Volatility (10-Day)

9.27%

PHIO Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-01-31

$2.06

-$0.16 (-7.21%)

$2.26

$2.27

$2.05

$2.13

798.28K ($1.64M)

2025-01-30

$2.22

-$0.06 (-2.63%)

$2.14

$2.35

$2.08

$2.22

804.49K ($1.79M)

2025-01-29

$2.28

-$0.27 (-10.59%)

$2.55

$2.63

$2.22

$2.38

2.27M ($5.18M)

2025-01-28

$2.55

$0.53 (26.24%)

$2.24

$2.86

$2

$2.47

10.42M ($26.57M)

2025-01-27

$2.02

-$0.19 (-8.6%)

$2.06

$2.23

$1.93

$2.06

718.94K ($1.45M)

2025-01-24

$2.21

-$0.13 (-5.56%)

$2.27

$2.39

$2.20

$2.27

539.53K ($1.19M)

2025-01-23

$2.34

$0.05 (2.18%)

$2.23

$2.37

$2.15

$2.29

670.30K ($1.57M)

2025-01-22

$2.29

-$0.19 (-7.66%)

$2.35

$2.49

$2.20

$2.33

1.02M ($2.33M)

2025-01-21

$2.48

-$0.29 (-10.47%)

$2.77

$2.80

$2.45

$2.58

1.43M ($3.54M)

2025-01-17

$2.77

-$0.14 (-4.81%)

$2.76

$2.89

$2.61

$2.76

2.11M ($5.85M)

PHIO Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $5.39M

    -36.27%

  • Total assets

    $5.87M

    -38.52%

  • Total liabilities

    $919.00K

    -60.49%

  • Total investments

    $0

    0%

  • Shareholders' equity

    $4.95M

    -31.43%

  • Book value per share

    $5.00

    69.01%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $0

    0%

  • Net income

    -$1.52M

    45.18%

  • Operating expense

    $1.59M

    -42.72%

  • Gross profit

    $0

    0%

  • EBITDA

    -$1.52M

    44.24%

  • Earnings per share

    -$1.54

    -35.09%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    $692.00K

    123.86%

  • Cash from operations

    -$1.95M

    32.66%

  • Cash from investing

    $0

    0%

  • Cash from financing

    $2.65M

    -

  • Free cash flow

    -$1.95M

    32.66%

  • Free cash flow per share

    -$1.97

    -66.08%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $2.97M

    -11.49%

  • Enterprise value

    -$1.73M

    78.11%

  • Shares outstanding

    860.72K

    -61.26%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    6.38

    59.13%